GlassScriptPhysician profile
Ramona Lyon
NPI 1700186475
$4,741.59
in general payments reported to CMS, 2019-2025
40 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,100 · 2022: $1,867 · 2023: $1,448 · 2024: $103 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $947.90 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $624.96 | 2022 | |
| Biogen, INC. | $295.85 | 2022-2025 | Vumerity, Tysabri, Plegridy |
| Ucb, INC. | $248.10 | 2021-2023 | Briviact |
| Biohaven Pharmaceuticals, INC. | $242.35 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $217.83 | 2021-2023 | Ajovy, Austedo Xr, Austedo |
| Amgen INC. | $191.91 | 2021-2023 | Aimovig |
| Sk Life Science, INC. | $172.37 | 2021-2023 | |
| Argenx US, INC. | $147.77 | 2023 | Vyvgart, Vyvgart Hytrulo |
| Lundbeck LLC | $118.96 | 2021-2023 | Vyepti |
| Dexcom, INC. | $106.83 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Boston Scientific Corporation | $102.00 | 2025 | Watchman Flx |
| Lilly USA, LLC | $94.14 | 2021-2023 | Emgality |
| Acorda Therapeutics, INC | $88.95 | 2022-2023 | Ampyra, Inbrija |
| Impel Pharmaceuticals INC. | $88.85 | 2022-2023 | Trudhesa |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.